Assistant Professor, Pediatrics-Children's Hospital, Harvard Medical School
Pediatric Hematology & Oncology
Dr. Katherine A. Janeway, MD
|
|
Give Review
Katherine A. Janeway, MD works in the field of Pediatric Hematology & Oncology. She studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care She has 1 awards "Regional Top Doctor". Doctor Katherine A. Janeway, MD is a published physician as well. She has 25 publications published. The latest was: Future directions in the treatment of osteosarcoma.
Publications
- Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
- Future directions in the treatment of Osteosarcoma.
- Marketing of personalized Cancer care on the web: an analysis of internet websites.
- Integrity of the pheochromocytoma susceptibility TMEM127 gene in pediatric Malignancies.
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in Osteosarcoma.
- Exploring the association of succinate dehydrogenase complex mutations with lymphoid Malignancies.
- Future of clinical genomics in pediatric oncology.
- Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor.
- New strategies in Sarcoma therapy: linking biology and novel agents.
- Pediatric gastrointestinal stromal tumor.
- Outcome for adolescent and young adult patients with Osteosarcoma: A report from the Children's Oncology Group.
- Differentiation of NUT midline carcinoma by epigenomic reprogramming.
- Circulating endothelial cells and circulating endothelial precursor cells in patients with Osteosarcoma.
- Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification.
- Modeling human Osteosarcoma in the mouse: From bedside to bench.
- Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
- Pediatric gastrointestinal stromal tumors.
- Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic ...
- Cardiac paraganglioma in an adolescent.
- Special considerations in pediatric gastrointestinal tumors.
- Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
- Sequelae of osteosarcoma medical therapy: a review of rare Acute toxicities and late effects.
- Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches.
- Carpal tunnel syndrome and workers' compensation among an occupational clinic population in New York State.
Schools
Harvard Medical School
Chldn39s Hospital
Dana Farber Canc Institute Chldns Hospital
Dana Farber Cancer Institute Chldns Hospital
Conditions Treated
- Acute Leukemia
- Deep Vein Thrombosis (DVT)
- Lung Cancer
- OsteoSarcoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Boston Children's Hospital -
Harvard Medical School
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Similar Doctors
|
|
Dr. A L. Frazier, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alejandro Gutierrez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erica B. Esrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Venee N. Tubman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Law, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathy G. Rosenfield, MD
This Doctor is OpenDoctor Recommended.
|